BiomX (PHGE) investor relations material

Executive summary

• Annual Meeting scheduled for June 26, 2026, to be held virtually; record date is June 2, 2026.

• Three proposals up for vote: election of one director, amendment to the 2026 Equity Incentive Plan, and adjournment if needed.

• Board unanimously recommends voting FOR all proposals.

• Proxy materials and annual report are available online; shareholders can vote by mail, phone, internet, or during the meeting.

Voting matters and shareholder proposals

• Proposal 1: Elect Ran Shaked as Class III director for a term ending 2029.

• Proposal 2: Approve amendment to increase shares reserved under the 2026 Equity Incentive Plan from 1,390,000 to 6,850,000.

• Proposal 3: Approve adjournment of the meeting if more time is needed to solicit proxies.

• Board recommends FOR all proposals; plurality required for director, majority for other proposals.

Board of directors and corporate governance

• Board consists of four members; three are independent under NYSE American standards.

• Committees: Audit (Liat Bidas, Chair), Compensation (Ran Shaked, Chair), Nominating and Corporate Governance (Liat Bidas, Chair).

• Board held 22 meetings in 2025; all directors attended at least 75% of meetings.

• No Chairman or lead independent director currently appointed.